51x Revenue Multiple, $146M in Losses — Here's Why Wall Street Is Betting $48 Billion on Cerebras Anyway
Cerebras Systems (CBRS) is set to debut on the Nasdaq on May 14, 2026, after raising its IPO price range to $150 to $160 per share, implying a fully diluted market cap of $48.8 billion — roughly 51 times its 2025 revenue of $510 million — while reporting a GAAP operating loss of $145.9 million and disclosing two material weaknesses in internal financial controls. Despite these contradictions, the offering attracted more than 20 times oversubscription, earning the label of the hottest IPO of 2026 and drawing comparisons to ARM Holdings' blockbuster 2023 debut. At the center of this frenzy is the Wafer Scale Engine 3 (WSE-3), a processor that treats an entire 300mm silicon wafer as a single chip — yielding 4 trillion transistors, 44GB of on-chip SRAM, and inference speeds that independent peer-reviewed research found to be 21 times faster than NVIDIA's Blackwell B200 GPU on real-world large language model workloads. Cerebras is entering public markets at the precise inflection point where AI spending is pivoting from model training to real-time inference, a structural shift Gartner expects will push inference to more than 65% of all AI-optimized infrastructure spending by 2029, and MarketsandMarkets projects will grow the global AI inference market from $106 billion in 2025 to nearly $255 billion by 2030. The deeper significance of this IPO is not the "NVIDIA killer" headline narrative — Cerebras is unlikely to displace NVIDIA in training — but rather what OpenAI's $20 billion multi-year supply agreement signals about a broader effort to decentralize AI infrastructure away from the hyperscaler triopoly of AWS, Azure, and Google Cloud.